Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Zostavax Global Market Report 2025
Request Sample Buy Now
Global Zostavax Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Zostavax Global Market Report 2025

By Formulation (Recombinant Vaccine (Shingrix), Live Attenuated Vaccine (Zostavax)), By Indication (Shingles Prevention, Post-Herpetic Neuralgia), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Zostavax Market?

Zostavax is a vaccine developed to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, which also causes chickenpox. It is primarily recommended for adults aged 50 and older to reduce the risk of developing shingles and its associated complications, such as postherpetic neuralgia.

The main types of zostavax formulations are recombinant vaccine (shingrix) and live attenuated vaccine (zostavax). A recombinant vaccine is made by using genetic engineering to produce an antigen that triggers an immune response without using a live virus. It is used for shingles prevention and post-herpetic neuralgia and is distributed through hospitals and retail pharmacies.

Zostavax Market Size and growth rate 2025 to 2029: Graph

What Is The Zostavax Market Size 2025 And Growth Rate?

The zostavax market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growth in preventive healthcare, an increase in vaccine accessibility, growth in insurance coverage, a rise in awareness about shingles and its complications, and the inclusion of shingles vaccines in national immunization programs.

What Is The Zostavax Market Growth Forecast?

The zostavax size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a surge in new shingles vaccine approvals by regulatory authorities, increasing cost-effectiveness of vaccines over treatments, a rise in new vaccine approvals, high adoption of shingrix among the developed countries, and increasing prevalence of chronic diseases. Major trends in the forecast period include a shift toward advanced products, emerging initiatives from companies in research and development of vaccines, government initiatives and public health campaigns, expanding outreach programs in rural areas to increase awareness and accessibility of the shingles vaccine, and technological advancement.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

How Is The Zostavax Market Segmented?

The zostavax market covered in this report is segmented –

1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax)

2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies

What Is Driving The Zostavax Market? Impact Of Healthcare Infrastructure Expansion On Vaccine Accessibility And Uptake

The expansion of healthcare infrastructure in developing countries is expected to propel the growth of the zostavax market going forward. Healthcare infrastructure refers to the integrated network of facilities, equipment, personnel, and systems required to deliver effective and efficient healthcare services to a population. The expansion of healthcare infrastructure in developing countries is primarily due to growing investments in healthcare facilities and improved access to medical services. Healthcare infrastructure supports zostavax by providing the necessary facilities, resources, and delivery systems to administer the vaccine to the target population, particularly in clinics, hospitals, and pharmacies. For instance, in May 2023, according to the Department of Health and Social Care, a UK-based government department, the UK government has confirmed that the New Hospital Programme receives over $25.33 billion (£20 billion) in investment, aimed at fulfilling the commitment to build 40 new hospitals in England by 2030. In addition to replacing five RAAC hospitals, the program includes three mental health hospitals as part of a broader effort to eliminate dormitory accommodation in mental health facilities and promote equality between physical and mental health care. Two hospitals have already been completed, five are under construction, and over 20 are set to be underway or completed by the end of next year. Therefore, the expansion of healthcare infrastructure in developing countries is driving the growth of the zostavax market.

What Is Driving The Zostavax Market? Impact Of Growing Geriatric Population On Vaccine Demand

The surge in the geriatric population is expected to propel the growth of the zostavax market going forward. The geriatric population refers to individuals who are typically aged 65 and older, often requiring specialized medical care due to age-related health issues. The geriatric population is increasing globally due to advancements in healthcare, improved living standards, and better disease management, which have contributed to longer life expectancies. Zostavax is required for the geriatric population because aging weakens the immune system, increasing the risk of developing shingles and its complications, making vaccination essential for prevention. For instance, in October 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, one in six people worldwide will be 60 years or older by 2030, with the population in this age group rising from 1 billion in 2020 to 1.4 billion. By 2050, the global population of individuals aged 60 and above is expected to double, reaching 2.1 billion. Additionally, the number of people aged 80 or older is projected to triple between 2020 and 2050, reaching 426 million. Therefore, the surge in the geriatric population is driving the growth of the zostavax market.

What Is Driving The Zostavax Market? Rising Insurance Coverage Driving Increased Vaccine Accessibility And Adoption

The growth in insurance coverage is expected to propel the growth of the zostavax market going forward. Insurance coverage refers to the protection provided by an insurance policy, where the insurer agrees to pay for certain financial losses or medical expenses incurred by the insured, based on the terms and conditions of the policy. Insurance coverage is rising due to increasing awareness of health risks, rising medical costs, and a growing demand for financial protection against unforeseen events and chronic conditions. Zostavax helps insurance coverage by providing a preventative vaccine for shingles, which reduces the risk of costly treatments and long-term healthcare expenses associated with the disease, thereby encouraging insurers to cover its cost as part of proactive health management for eligible individuals, particularly those aged 50 and above. For instance, in December 2023, according to the U.S. Centers for Medicare & Medicaid Services, a US-based federal agency, the proportion of the population with insurance reached a historic high of 92% in 2022. Enrollment in Medicaid increased by 6.1 million people, while enrollment in private health insurance increased by 2.9 million people. Therefore, the growth in insurance coverage is driving the growth of the zostavax market.

Who Are The Major Players In The Global Zostavax Market?

Major companies operating in the zostavax market are Merck & Co. Inc.

Need data on a specific region in this market?
Request Customisation

Regional Analysis For The Global Zostavax Market

North America was the largest region in the zostavax market in 2024. The regions covered in the zostavax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the zostavax market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Zostavax Market?

The zostavax market consists of sales of flu vaccines, pneumococcal vaccines hepatitis vaccines and meningitis vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Zostavax Industry?

The zostavax market research report is one of a series of new reports from The Business Research Company that provides zostavax market statistics, including zostavax industry global market size, regional shares, competitors with a zostavax market share, detailed zostavax market segments, market trends and opportunities, and any further data you may need to thrive in the zostavax industry. This zostavax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Zostavax Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The zostavax market covered in this report is segmented –
1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax)
2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co. Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Zostavax Market Characteristics

3. Zostavax Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Zostavax Market Trends And Strategies

5. Zostavax Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Zostavax Growth Analysis And Strategic Analysis Framework

6.1. Global Zostavax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Zostavax Market Growth Rate Analysis

6.4. Global Zostavax Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Zostavax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Zostavax Total Addressable Market (TAM)

7. Global Zostavax Pricing Analysis & Forecasts

8. Zostavax Market Segmentation

8.1. Global Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Recombinant Vaccine (Shingrix)

Live Attenuated Vaccine (Zostavax)

8.2. Global Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Shingles Prevention

Post-Herpetic Neuralgia

8.3. Global Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Retail Pharmacies

9. Global Zostavax Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Zostavax Market Regional And Country Analysis

10.1. Global Zostavax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Zostavax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Zostavax Market

11.1. Asia-Pacific Zostavax Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Zostavax Market

12.1. China Zostavax Market Overview

12.2. China Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Zostavax Market

13.1. India Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Zostavax Market

14.1. Japan Zostavax Market Overview

14.2. Japan Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Zostavax Market

15.1. Australia Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Zostavax Market

16.1. South Korea Zostavax Market Overview

16.2. South Korea Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Zostavax Market

17.1. Western Europe Zostavax Market Overview

17.2. Western Europe Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Zostavax Market

18.1. UK Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Zostavax Market

19.1. Germany Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Zostavax Market

20.1. France Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Zostavax Market

21.1. Eastern Europe Zostavax Market Overview

21.2. Eastern Europe Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Zostavax Market

22.1. North America Zostavax Market Overview

22.2. North America Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Zostavax Market

23.1. USA Zostavax Market Overview

23.2. USA Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Zostavax Market

24.1. Canada Zostavax Market Overview

24.2. Canada Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Zostavax Market

25.1. South America Zostavax Market Overview

25.2. South America Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Zostavax Market

26.1. Middle East Zostavax Market Overview

26.2. Middle East Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Zostavax Market

27.1. Africa Zostavax Market Overview

27.2. Africa Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Zostavax Market Competitive Landscape And Company Profiles

28.1. Zostavax Market Competitive Landscape

28.2. Zostavax Market Company Profiles

28.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Zostavax Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Zostavax Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Zostavax Market

32. Recent Developments In The Zostavax Market

33. Zostavax Market High Potential Countries, Segments and Strategies

33.1 Zostavax Market In 2029 - Countries Offering Most New Opportunities

33.2 Zostavax Market In 2029 - Segments Offering Most New Opportunities

33.3 Zostavax Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

Need tailored insights? Customise this report to fit your business goals.

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Zostavax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Zostavax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Merck & Co. Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Zostavax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Zostavax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Merck & Co. Inc. Financial Performance

Comprehensive Forecast: Complementary And Alternative Medicine For Anti-Aging And Longevity Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Complementary And Alternative Medicine For Anti-Aging And Longevity Market Share, Growth, and Opportunities Through 2029

Global Compounding Chemotherapy Market Landscape: Trends and Market Share to 2029

Read More About Global Compounding Chemotherapy Market Landscape: Trends and Market Share to 2029

Industry Trends Show Connective Tissue Disease Treatment Market Set to Expand at 6.1% CAGR Until 2029

Read More About Industry Trends Show Connective Tissue Disease Treatment Market Set to Expand at 6.1% CAGR Until 2029

Strategic Report on Consumer Health Contract Manufacturing Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Consumer Health Contract Manufacturing Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Factoring Market 2023 – By Type (Recourse, Non-Recourse), By Organization Size (Small And Medium Enterprises, Large Enterprises), By Category (International, Domestic), By Application (Transportation, Healthcare, Constru...

View Report

Automotive Performance Tuning And Engine Remapping Services Global Market Report 2025 – By Service (Engine Tuning, Suspension Tuning, Transmission Tuning, Interior Tuning, Exterior Tunning), By Fuel Type (Petrol, Diesel)...

View Report

Cardiac Safety Services Global Market Report 2025 – By Services (ECG Or Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitorin...

View Report

Plant-Based Vaccines Global Market Report 2025 – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application (Infl...

View Report

Preclinical Assets Global Market Report 2025 – By Service (Bioanalysis And DMPK (Drug Metabolism and Pharmacokinetic) studies, Toxicology Testing, Compound Management, Safety Pharmacology, Other Services), By Model Type ...

View Report

Frequently Asked Questions

Zostavax is a vaccine developed to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, which also causes chickenpox. It is primarily recommended for adults aged 50 and older to reduce the risk of developing shingles and its associated complications, such as postherpetic neuralgia. For further insights on the Zostavax market, request a sample here

The Zostavax market major growth driver - Impact Of Healthcare Infrastructure Expansion On Vaccine Accessibility And Uptake. For further insights on the Zostavax market, request a sample here

The Zostavax market size has grown strongly in recent years. The zostavax market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growth in preventive healthcare, an increase in vaccine accessibility, growth in insurance coverage, a rise in awareness about shingles and its complications, and the inclusion of shingles vaccines in national immunization programs. The zostavax size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a surge in new shingles vaccine approvals by regulatory authorities, increasing cost-effectiveness of vaccines over treatments, a rise in new vaccine approvals, high adoption of shingrix among the developed countries, and increasing prevalence of chronic diseases. Major trends in the forecast period include a shift toward advanced products, emerging initiatives from companies in research and development of vaccines, government initiatives and public health campaigns, expanding outreach programs in rural areas to increase awareness and accessibility of the shingles vaccine, and technological advancement. For further insights on the Zostavax market, request a sample here

The zostavax market covered in this report is segmented –
1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax)
2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies For further insights on the Zostavax market, request a sample here

North America was the largest region in the zostavax market in 2024. The regions covered in the zostavax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Zostavax market, request a sample here.

Major companies operating in the zostavax market are Merck & Co. Inc. . For further insights on the Zostavax market, request a sample here.

Major trends in the Zostavax market include . For further insights on the Zostavax market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Zostavax Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top
\
Back to top